Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 1.00 |
| ▸ | ERN1 | O75460 | 1/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | ALB | P02768 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7873607 | 0.88 | TTR (0.78) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL27280320 | 0.80 | TTR (0.64) | TTRERN1LMNAKMT2ARPS6KA3 | |
| SCHEMBL350953 | 0.80 | TTR (0.64) | TTRERN1MEN1LMNAHTT | |
| SCHEMBL2049716 | 0.80 | TTR (0.64) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL7927726 | 0.80 | GABRA1 (0.78) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL11613562 | 0.80 | TTR (0.65) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL7932590 | 0.80 | TTR (0.65) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL1530279 | 0.80 | TTR (0.65) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL28010687 | 0.80 | TTR (0.65) | TTRERN1GABRA1GABRB1GABRB2 | |
| SCHEMBL11747447 | 0.80 | TTR (0.65) | TTRERN1GABRA1GABRB1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3595581-B1 | VASCULAR PROSTHESIS FOR LEAK PREVENTION DURING ENDOVASCULAR ANEURYSM REPAIR | TEXAS A & M UNIV SYS (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4376905-B1 | COMPOSITIONS FOR EMBOLIZATION | IBERHOSPITEX SA (ES) | 2025-10-22 | — | — | EP | claimed |
| WO-2025120339-A1 | AMINOALKYLATED BENZOXY COMPOUNDS FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | Szegedi Tudományegyetem (HU) | 2025-06-12 | — | — | WO | claimed |
| US-12269790-B1 | Process for the preparation of 2,4,6-triiodophenol derivatives | BRACCO IMAGING S.P.A. (IT) | 2025-04-08 | — | — | US | claimed |
| US-20250109094-A1 | PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOPHENOL DERIVATIVES | BRACCO IMAGING S.P.A. (IT) | 2025-04-03 | — | — | US | claimed |
| CN-119095823-A | Process for preparing 2,4, 6-triiodophenol derivatives | 伯拉考成像股份公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118549570-A | Detection method of 13 disinfection byproducts in sediment | 上海市环境科学研究院 | 2024-08-27 | — | — | CN | claimed |
| CN-114113370-B | Analysis method of aromatic halogenated disinfection byproducts in water | 东南大学 | 2024-03-26 | — | — | CN | claimed |
| WO-2023209165-A1 | PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOPHENOL DERIVATIVES | BRACCO IMAGING SPA (IT) | 2023-11-02 | — | — | WO | claimed |
| CN-113466281-B | Based on 1 Quantification method of total ginsenoside in H qNMR Shenmai injection | 正大青春宝药业有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-5411852-A | A phenol with at least two iodo substituents | EASTMAN KODAK COMPANY (US) | 1995-05-02 | — | — | US | claimed |
| EP-0578765-A1 | DELIVERY OF X-RAY CONTRAST AGENTS USING RECEPTOR MEDIATED ENDOCYTOSIS | ADVANCED MAGNETICS INCORPORATED (US) | 1994-01-19 | — | — | EP | claimed |
| WO-1992017216-A1 | DELIVERY OF X-RAY CONTRAST AGENTS USING RECEPTOR MEDIATED ENDOCYTOSIS | ADVANCED MAGNETICS, INC. (US) | 1992-10-15 | — | — | WO | claimed |
| US-4727089-A | RHEUMATIC DISEASES | BISLAK, S.A. (ES) | 1988-02-23 | — | — | US | claimed |
| US-4727090-A | CARDIOVASCULAR DISORDERS | BISLAK, S.A. (ES) | 1988-02-23 | — | — | US | claimed |
| US-4677124-A | TREATMENT OF ATHEROSCLEROSIS | BISLAK, S.A. (ES) | 1987-06-30 | — | — | US | claimed |
| EP-0147892-A2 | Process for preparing and therapeutical applications of the 2,4,6-triiodophenol | BISLAK, S.A. (ES) | 1985-07-10 | — | — | EP | claimed |
| EP-0070198-B1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME | Hitachi, Ltd. (JP) | 1985-06-19 | — | — | EP | claimed |
| EP-0070198-A1 | Radiation-sensitive composition and pattern-formation method using the same | Hitachi, Ltd. (JP) | 1983-01-19 | — | — | EP | claimed |
| US-4179499-A | HYDROXYPHENYL-SUBSTITUTED AMIDE, EDIBLE BINDER, BAIT, CARRIER | LONZA LTD. (CH) | 1979-12-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109094-A1 | PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOPHENOL DERIVATIVES | TPO, IPO4, CYP4F2 | TTR 63/4885ERN1 3476/4885GABRA1 4226/4885 |
| US-12269790-B1 | Process for the preparation of 2,4,6-triiodophenol derivatives | TPO, IPO4, CYP4F2 | TTR 63/4885ERN1 3476/4885GABRA1 4226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.